001360.KO Samsung Pharm

Healthcare Pharmaceuticals Korea Stock Exchange
1,263 KRW
Close of Nov 5, 2026
1,140 2,320
Market cap
KRW 119B
P/E
9.3x
P/B
1.64x
ROE
-132.5%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 001360.KO undervalued?

Graham number
Price1,263
Graham value1,529
Discount17.4%

001360.KO trades 17.4% below its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Samsung Pharm fundamental analysis

No fundamental analysis for Samsung Pharm yet.

Samsung Pharm stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Samsung Pharm

SAMSUNG PHARM. Co., LTD. manufactures and sells pharmaceutical products in South Korea. It offers prescription medicines, such as anticancer immunotherapy, antipyretic analgestic and antiinflammatory, antiobesity, hypotensive, antiarteriosclerotic, digestive organs, antophlegms, enzymes, ostepoposis, and transfusion agents, as well as skeletal muscle relaxants, anti-spastic, enzyme, mixed vitamins, antibiotics, and others. The company also provides medicines for the digestiv…

Full company profile